Related Experiment Videos
[The mechanisms of glomerulonephritis progression]
Terapevticheskii Arkhiv
|January 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[The course and prognosis of mesangioproliferative glomerulonephritis].
Terapevticheskii arkhiv·2002
[Renal and uterine hemodynamics in pregnant women with hypertension].
Terapevticheskii arkhiv·2002
Correlation between the expression of DNA topoisomerases I and IIalpha and clinical parameters in kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
[Kidney damage in primary antiphospholipid syndrome].
Terapevticheskii arkhiv·2001
Expression of DNA topoisomerases in chronic proliferative kidney disease.
Kidney international·2000
[Primary focal segmental glomerulosclerosis: clinical and morphological prognostic factors].
Terapevticheskii arkhiv·2000
[History of the Moscow Scientific Society of Cardiology].
Terapevticheskii arkhiv·2026
[Antiphospholipid syndrome: ophthalmologic manifestations. A review].
Terapevticheskii arkhiv·2026
[Uric acid and mitochondrial dysfunction: a review].
Terapevticheskii arkhiv·2026
[Rheumatoid nodule in the myocardium as part of the chain in a clinical detective. Case report].
Terapevticheskii arkhiv·2026
[Cutaneous manifestations of systemic lupus erythematosus and coexisting dermatologic conditions].
Terapevticheskii arkhiv·2026
Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β.
Journal of Zhejiang University. Science. B·2026
Incidence and clinical characteristics of amyotrophic lateral sclerosis during the post-COVID-19 Period: a population-based study from Isfahan, Iran.
Neurodegenerative disease management·2026